Candel Therapeutics to Host Virtual R&D Event on December 5, 2025 Nov 17, 2025 04:05PM
Candel Therapeutics to Host Virtual R&D Event on December 5, 2025 Nov 17, 2025 04:05PM
Candel Therapeutics to Present at the Canaccord Genuity 45th Annual Growth Conference Jul 30, 2025 08:05AM
Candel Therapeutics Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares Dec 16, 2024 04:01PM
Candel Therapeutics Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares Dec 16, 2024 04:01PM


Dec 13, 2024 07:32AM Candel Therapeutics (CADL) Prices Public Offering
Dec 12, 2024 11:00PM Candel Therapeutics Announces Pricing of Public Offering
Dec 12, 2024 04:52PM Candel Therapeutics (CADL) Announces $80 Million Proposed Public Offering
Dec 12, 2024 04:51PM Candel Therapeutics Announces $80 Million Proposed Public Offering
Aug 2, 2023 08:00AM Candel Therapeutics to Participate in the Canaccord Genuity 43rd Annual Growth Conference